MedPath
FDA Approval

Atovaquone and Proguanil Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 12, 2013
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Proguanil(100 mg in 1 1)
Atovaquone(250 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Atovaquone and Proguanil Hydrochloride

Product Details

NDC Product Code
54868-6393
Application Number
ANDA091211
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 12, 2013
ProguanilActive
Code: R71Y86M0WTClass: ACTIBQuantity: 100 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JGClass: IACT
Code: Y883P1Z2LTClass: ACTIBQuantity: 250 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3BClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTEDInactive
Code: 2165RE0K14Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath